General Information of Drug (ID: DMV5MED)

Drug Name
TVI-Brain-1
Indication
Disease Entry ICD 11 Status REF
Glioblastoma 2A00 Phase 2/3 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D5A6JN

References

1 ClinicalTrials.gov (NCT05685004) Randomized Phase 2b Study of Safety And Efficacy Of TVI-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Vs Standard Therapy In Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM). U.S.National Institutes of Health.